ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Status and influencing factors of resilience among patients with lung cancer undergoing chemotherapy: a qualitative study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo explore the current situation and influencing factors of resilience in patients with lung cancer undergoing chemotherapy, and to provide a basis for constructing a comprehensive and effective resilience enhancement program for patients with lung cancer undergoing chemotherapy.
methodsUsing descriptive qualitative research and purposive sampling method, 20 patients with lung cancer undergoing chemotherapy from October to December 2024 in the oncology department of a tertiary general hospital in Wuxi City, Jiangsu Province, China were interviewed semi-structured. The data were organized and coded with the help of Nvivo 14.0 software, and themes were distilled using the traditional content analysis method.
resultsA total of three themes and eight sub-themes were derived. The resilience status of patients with lung cancer undergoing chemotherapy was reflected in cognitive deficiency and a casual attitude. The protective factors for resilience among patients with lung cancer undergoing chemotherapy included intrinsic positive traits, multiple support networks, and professional medical support. The risk factors for resilience among patients with lung cancer undergoing chemotherapy included the damage of disease treatment, heavy economic burden, and lack of disease knowledge.
conclusionsThe study found that resilience among patients with lung cancer undergoing chemotherapy is multifaceted, shaped by a complex interplay of factors. Medical care, family, and society should jointly provide help to promote the protective factors of resilience and overcome the risk factors of resilience through collaborative efforts aimed at bolstering resilience, ultimately enhancing the quality of life for patients with lung cancer during chemotherapy.
Indexed as
Identifiers
41790266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.